| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2871247 | The Annals of Thoracic Surgery | 2016 | 8 Pages |
Abstract
Adjuvant chemotherapy is a favorable prognostic factor for the probability of FFR in patients with stage IB lung adenocarcinoma, particularly in those with a micropapillary/solid-predominant pattern.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jung-Jyh MD, PhD, Yu-Chung MD, Teh-Ying MD, PhD, Wen-Juei MD, Yi-Chen MD, Wen-Hu MD,